Presented as part of its effort to lower what it views as excessive prices for prescription drugs, the Biden administration on December 7, 2023, announced the release of a proposed framework to expand the use of government...more
12/19/2023
/ Bayh-Dole Act ,
Biden Administration ,
Drug Pricing ,
Executive Orders ,
Federal Funding ,
March-in-Rights ,
National Institute of Health (NIH) ,
NIST ,
Pharmaceutical Industry ,
Prescription Drugs ,
Research and Development